Dapagliflozina helps type 2 diabetes if insulin is insufficient
new YORK (Reuters Health) – type 2 diabetics they could not control their levels of glucose with high doses insulin improved levels of HbA1c and loss sustained weight once they added dapagliflozina in one recent proof. however, the researchers reported in the journal Annals of Internal Medicine patients had more episodes of minor hypoglycemia. The dapagliflozina selectively inhibits the cotransportador proteins type 2, for increase urinary excretion of glucose, according to Dr. John p. H. Wilding and his colleagues of the University hospital Aintree in Liverpool, Great Britain. 808 Patients in 24 weeks testing had high levels of glucose in the blood despite taking at least 30 Or daily insulin. The research team assigned to the random 2.5, 5 or 10 mg of dapagliflozina once a day, or a placebo. After 24 weeks, the average HbA1c level fell up 0.96% in groups of dapagliflozina in comparison with a 0.39 percent fall in the Group of placebo. Specifically, differences in the changes of the HbA1c among placebo patients and patients with 2.5, 5 and 10 mg/d of dapagliflozina was – 0.40 percent, – 0.49 by percent, and – 0.57 percent respectively, the report said. Body weight decreased with the dapagliflozina and increased with placebo, with respective differences in changes of weight in the three groups with dapagliflozina-1.35 kg, – 1.42 kg and – 2.04 kg compared with placebo groups. In...
Read More